eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-ZLAB-Zai Lab Limited

Zai Lab Limited ZLAB

$32.800.32(0.99%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Zai Lab Limited
Today
Create an eToro account to buy ZLAB stock on a secure, user-friendly, multi-asset trading platform.
Buy Zai Lab Limited
Buy Zai Lab Limited
Zai Lab Limited ZLAB
Buy ZLAB
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
69.00
Based on analysts who covered ZLAB

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Zai Lab Limited News

About Zai Lab Limited
Zai Lab Limited is a research-based, commercial stage, global biopharmaceutical company headquartered in Shanghai, China. The firm is engaged in the discovery, licensing, development, and commercialisation of proprietary therapeutics that primarily address areas of unmet medical need in the fields of infectious diseases, oncology, and autoimmune diseases. The company was founded in 2014.

The company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. The firm has also brought various products to market in China, including Zejula which is a maintenance therapy for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, Optune, which is for the treatment of patients with newly diagnosed glioblastoma, and Qinlock, which is for the treatment of adult patients with advanced gastrointestinal stromal tumour.

The firm has built an internal Research & Development centre as well as their own manufacturing facilities in China and has become a trusted partner of choice for global biopharmaceutical companies seeking to access the Chinese market and develop long-term strategic partnerships for global clinical development. The firm is listed on the NASDAQ where it trades under the ticker ZLAB.

Track the share price of ZLAB by adding it to your eToro virtual portfolio.
VIEW MORE   

ZLAB Stock Price Chart

‎-3.98‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Zai Lab Limited share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Zai Lab Limited share price today is $32.80, reflecting a ‎0.99‎% change over the last 24 hours and ‎6.67‎% over the past week. The current market capitalization of ZLAB is $3.65B with an average volume in the last three months of 782432.14. The stock has a P/E ratio of -16.02 and a dividend yield of 0%. With the stock’s beta sitting at 1.15
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$3.65B
Day’s Range
i
Shows the high and low prices of the day.
$32.16 - $32.86
52W Range
i
Shows the high and low prices of the last year.
$13.31 - $44.03
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
782432.14
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-16.02
Revenue
i
The total income generated by this company’s goods and services last year.
$427.8M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
$0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$32.8
EPS
i
A company’s total earnings divided by the number of shares it has issued.
$-2.05
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.15
What Is Zai Lab Limited?
Zai Lab Limited is a research-based, commercial stage, global biopharmaceutical company headquartered in Shanghai, China. The firm is engaged in the discovery, licensing, development, and commercialisation of proprietary therapeutics that primarily address areas of unmet medical need in the fields of infectious diseases, oncology, and autoimmune diseases. The company was founded in 2014.

The company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. The firm has also brought various products to market in China, including Zejula which is a maintenance therapy for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, Optune, which is for the treatment of patients with newly diagnosed glioblastoma, and Qinlock, which is for the treatment of adult patients with advanced gastrointestinal stromal tumour.

The firm has built an internal Research & Development centre as well as their own manufacturing facilities in China and has become a trusted partner of choice for global biopharmaceutical companies seeking to access the Chinese market and develop long-term strategic partnerships for global clinical development. The firm is listed on the NASDAQ where it trades under the ticker ZLAB.

Track the share price of ZLAB by adding it to your eToro virtual portfolio.
Buy ZLAB

How can I buy Zai Lab Limited stocks?

To purchase Zai Lab Limited:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Zai Lab Limited (ZLAB) page and place an order to buy Zai Lab Limited.
Buy ZLAB
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Zai Lab Limited
Invest in Zai Lab Limited
Today
Create an eToro account to buy ZLAB stock on a secure, user-friendly, multi-asset trading platform.
Buy ZLAB

FAQ

The current price of ZLAB is $32.80.
The average price target for Zai Lab Limited is $69.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Zai Lab Limited based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Zai Lab Limited is $3.65B
Based on 1 analysts offering recommendations for ZLAB in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top